• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Talanta . Detection of antibodies against SARS-CoV-2 Spike protein by screen-printed carbon electrodes modified by colloidal gold nanoparticles

tetano

Editor, Senior Moderator
Talanta


. 2023 Oct 13;268(Pt 1):125279.
doi: 10.1016/j.talanta.2023.125279. Online ahead of print. Detection of antibodies against SARS-CoV-2 Spike protein by screen-printed carbon electrodes modified by colloidal gold nanoparticles

Ausra Baradoke[SUP] 1 [/SUP], Ainis Jarusaitis[SUP] 2 [/SUP], Viktorija Reinikovaite[SUP] 2 [/SUP], Ali Jafarov[SUP] 3 [/SUP], Alexandra Elsakova[SUP] 4 [/SUP], Marius Franckevicius[SUP] 1 [/SUP], Martynas Skapas[SUP] 1 [/SUP], Rimantas Slibinskas[SUP] 5 [/SUP], Maryia Drobysh[SUP] 2 [/SUP], Viktorija Liustrovaite[SUP] 2 [/SUP], Arunas Ramanavicius[SUP] 6 [/SUP]



Affiliations
Abstract

In this work, electrochemical bioanalytical systems for the determination of antibodies against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike protein (anti-rS) is reported. Environmentally friendly chemicals were applied in the synthesis of gold nanoparticles (AuNPs). The AuNPs were integrated onto the screen-printed carbon electrodes (SPE), and the biological recognition part was based on recombinant SARS-CoV-2 Spike protein (rS), which during the immobilization was cross-linked by glutaraldehyde. Immobilized rS protein based biological recognition part enabled selective recognition of anti-rS antibodies. The current flux of AuNPs reduction (at +200 mV) in a pure phosphate buffer (PB) was employed as the transduction signal. It has been reported that the formation of anti-rS layers on the surface of AuNPs delays the electrode response time (t[SUB]s[/SUB]), tracked at the current flux density values of 80 μA cm[SUP]-2[/SUP]. Using the AuNP-modified SPE, we demonstrated a rapid anti-rS detection within a detection limit of 2 ng mL[SUP]-1[/SUP] (0.125 binding antibody units mL[SUP]-1[/SUP], 17 pM). This system can be applied to track the response of immune system towards SARS-CoV-2 infection and monitoring of Coronavirus Disease 2019 (COVID-19).

Keywords: COVID-19; Chronoamperometry; Cyclic voltammetry; Electrochemistry; Gold nanoparticles (AuNPs); Green synthesis; SARS-CoV-2.

 
Back
Top Bottom